US Stock MarketDetailed Quotes
Theravance Biopharma (TBPH)
- 17.020
- -0.020-0.12%
Close Sep 18 16:00 ET
- 17.020
- 0.0000.00%
Post 19:30 ET
883.66MMarket Cap16.37P/E (TTM)
17.050High17.020Low683.74KVolume17.030Open17.040Prev Close11.64MTurnover2.64%Turnover Ratio8.26P/E (Static)51.92MShares21.03052wk High3.05P/B440.08MFloat Cap13.08052wk Low--Dividend TTM25.86MShs Float124.866Highest--Div Yield TTM0.18%Range %6.100Lowest17.027Avg Price1Lot Size
Theravance Biopharma (TBPH) Key Financial Indicators
TBPH Earnings per Share (EPS)
According to the latest financial report of Theravance Biopharma, the latest earnings per share (TTM) for the company is -0.11. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
TBPH Free Cash Flow (FCF)
Interested in knowing about Theravance Biopharma's free cash flow? The latest report shows it as -6.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
TBPH Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Theravance Biopharma shows that the company's current ratio is 13.54, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
TBPH Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Theravance Biopharma, the quick ratio is 13.26, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
TBPH Return on Equity (ROE)
Want to learn more about the financial health of Theravance Biopharma? The latest ROE figure is -2.03%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
TBPH Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Theravance Biopharma, the total asset return on investment (ROA) is -1.25%.
Currency: USD
Quarterly
Loading...
TBPH Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Theravance Biopharma's latest financial report to see how their gross margin is doing - currently at 95.98%.
Currency: USD
Quarterly
Loading...
TBPH Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Theravance Biopharma, the net profit margin is -28.45%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...